Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains..
Share this article
Corporate
Score 85
Bullish
Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains.
Mar 24, 2026 18:00 UTC
GILD, XLV, IHF
Medium term
Related Articles
Score 25
Novo Nordisk Chairman Under Scrutiny Amid Investor Skepticism
Mar 26, 05:00
Score 65
Bullish
Stonepeak on Investing in Infrastructure
Mar 26, 04:38
Score 35
Bullish
Baozun: Gap Plans to Open 50 Stores in China This Year
Mar 26, 04:37
Score 75
Henkel Approaching Deal to Acquire Premium Hair Care Brand Olaplex
Mar 26, 00:43
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.